`Mylan Pharmaceuticals Inc.
`Joseph M. Reisman
`Jay R. Deshmukh
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (949) 760-9502
`Ph.: (949) 760-0404
`E-mail: BoxMylan@knobbe.com
`
`By:
`
`
`
`
`
`
`
`
`
`
`Filed: December 10, 2014
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`Patent Owners
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2015-00265
`Patent 6,316,023
`
`
`
`
`
`
`
`
`
`
`
`
`MOTION FOR WILLIAM R. ZIMMERMAN TO APPEAR
`PRO HAC VICE ON BEHALF OF PETITIONER
`
`
`
`IPR2015-00265
`Mylan v. Novartis
`
`
`I.
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED
`
`Pursuant to the Board’s Notice of Filing Date (Paper 6) and 37 C.F.R. §§
`
`42.10(c) and 42.22, Petitioner Mylan Pharmaceuticals Inc. (“Mylan”) hereby
`
`moves for an Order allowing William R. Zimmerman of Knobbe, Martens, Olson
`
`& Bear, LLP to appear pro hac vice on behalf of Mylan in the above-captioned
`
`case.
`
`II. LIST OF EXHIBITS RELIED UPON FOR THIS MOTION
`
`
`
`Mylan Ex. 1026 - Declaration of William R. Zimmerman in Support
`
`of Motion to Appear Pro Hac Vice on Behalf of Petitioner.
`
`III. REASONS THE REQUESTED RELIEF SHOULD BE GRANTED
`
`As set forth below in the Statement of Material Facts, Mylan has made all of
`
`the showings required under 37 C.F.R. § 42.10(c) for recognizing Mr. Zimmerman
`
`pro hac vice. In particular, Mr. Zimmerman is an experienced litigating attorney
`
`who has represented clients in numerous patent litigation cases in various United
`
`States District Courts and the Court of Appeals for the Federal Circuit, including
`
`technically and legally complex matters such as will be present in this proceeding.
`
`Accordingly, allowing Mr. Zimmerman to appear pro hac vice on behalf of Mylan
`
`is appropriate in this proceeding.
`
`1
`
`
`
`IPR2015-00265
`Mylan v. Novartis
`
`
`IV. STATEMENT OF MATERIAL FACTS
`
`1.
`
`37 C.F.R. § 42.10(c) provides that “[t]he Board may recognize
`
`counsel pro hac vice during a proceeding upon a showing of good cause, subject
`
`to the condition that lead counsel be a registered practitioner and to any other
`
`conditions as the Board may impose. For example, where the lead counsel is a
`
`registered practitioner, a motion to appear pro hac vice by counsel who is not a
`
`registered practitioner may be granted upon showing that counsel is an
`
`experienced litigating attorney and has an established familiarity with the subject
`
`matter at issue in the proceeding.”
`
`2.
`
`Lead counsel in this inter partes review proceeding is Joseph M.
`
`Reisman. Mr. Reisman is registered to practice before the United States Patent and
`
`Trademark Office and holds Registration No. 43,878.
`
`3.
`
`As set forth in Mylan Exhibit 1026 (the “Zimmerman Decl.”), Mr.
`
`Zimmerman is an experienced litigating attorney and has an established familiarity
`
`with the subject matter at issue in this proceeding. Zimmerman Decl. ¶ 4. In
`
`particular, Mr. Zimmerman has over 16 years of experience as a patent litigator
`
`and has represented clients in numerous patent litigation cases in various United
`
`States District Courts and the Court of Appeals for the Federal Circuit. Id. ¶¶ 2, 3.
`
`In addition, Mr. Zimmerman has experience in inter partes review proceedings, for
`
`2
`
`
`
`IPR2015-00265
`Mylan v. Novartis
`
`example, IPR2013-00024, IPR2013-00128, IPR2013-00266, IPR2013-00517,
`
`IPR2013-00518, and IPR2014-01093. Id. ¶ 2.
`
`4.
`
`Further, Mr. Zimmerman holds a Bachelor of Science degree in
`
`Chemical Engineering from the University of Notre Dame and served as a law
`
`clerk to the Honorable Alvin A. Schall, Circuit Judge of the United States Court of
`
`Appeals for the Federal Circuit. Id. ¶ 3. Moreover, Mr. Zimmerman is
`
`experienced with technically and legally complex matters in the field of chemistry
`
`and biotechnology. Id.
`
`5. With regard to U.S. Patent No. 6,316,023 (“the ’023 patent”), the
`
`patent at issue in this proceeding, Mr. Zimmerman is familiar with the ’023 patent,
`
`and with the legal subject matter, technical subject matter, and prior art discussed
`
`in Mylan’s petition for inter partes review of the ’023 patent, which forms the
`
`basis of this proceeding. Id. ¶ 4. In view of his legal experience, technical
`
`background, and familiarity with the issues in the present matter, Mylan has
`
`requested his services in the present matter. Denial of his appearance in this case
`
`would create an undue burden on Mylan. Id.
`
`3
`
`
`
`IPR2015-00265
`Mylan v. Novartis
`
`
`
`6. Mr. Zimmerman has read and will comply with the Office Patent Trial
`
`Practice Guide and the Board’s Rules of Practice for Trials set forth in Part 42 of
`
`the C.F.R. Id. ¶ 9. Mr. Zimmerman also agrees to be subject to the United States
`
`Patent and Trademark Office Rules of Professional Conduct set forth in 37 C.F.R.
`
`§§ 11.101 et seq., and disciplinary jurisdiction under 37 C.F.R. § 11.19(a). Id. ¶ 10.
`
`7.
`
`Finally, Mr. Zimmerman has attested to the remaining elements of
`
`Paragraph 2(b) of the representative “Order – Authorizing Motion for Pro Hac
`
`Vice Admission” in Case IPR2013-00639, Paper 7. Id. ¶¶ 4-11; see Notice of
`
`Filing Date Accorded to Petition and Time for Filing Patent Owner Preliminary
`
`Response (Paper 6) at 2.
`
`V. CONCLUSION
`
`In view of the foregoing, and having satisfied the requirements of 37 C.F.R.
`
`§ 42.10(c), Mylan hereby moves for an Order allowing William R. Zimmerman
`
`of Knobbe, Martens, Olson, & Bear, LLP to appear pro hac vice on behalf of
`
`Mylan in the above-captioned case.
`
`
`
`
`
`
`
`4
`
`
`
`IPR2015-00265
`
`Mylan V. Novartis
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`Dated: December 10 2014
`
`flfl?
`
`By.
`
`oseph M. Reisman
`Reg. No. 43,878
`Customer No. 20,995
`
`
`
`Attorneys for Petitioner
`MYLAN PHARMACEUTICALS INC.
`
`(949) 760-0404
`
`
`
`IPR2015-00265
`
`Mylan V. Novartis
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the foregoing MOTION
`
`FOR WILLIAM R. ZIMMERMAN TO APPEAR PRO HAC VICE ON
`
`BEHALF OF PETITIONER is being served on December 10, 2014, Via email
`
`pursuant to 37 CPR. § 42.6(e) per agreement of the parties,
`
`to counsel for
`
`Novartis AG and LTS Lohmann Therapie-Systeme AG at the address below:
`
`ExelonPatchIPR@fchscom
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104
`
` Dated: December 10 2014
`
`19390003
`
`
`
`Jos h M. Reisman, Reg. No. 43,878
`Attorney for Petitioner
`Mylan Pharmaceuticals Inc.
`
`
`
`